–   Update on regulatory strategy for govorestat for the treatment of CMT-SORD following receipt of Type C meeting minutes –   Meeting scheduled with the FDA in 4Q 2025 to discuss govorestat for the treatment of Classic Galactosemia –   New data on govorestat for the treatment of PMM2-CDG published in JIMD and presented at the 2025 ASHG Annual Meeting –   Announces Board of Directors Leadership Transition NEW YORK, Nov. 13, 2025 (GLOBE NEWSWIRE) — Applied Therapeutics, Inc. (Nasdaq: APLT) (the “Company”), a clinical-stage biopharmaceutical company dedicated to creating transformative treatments for rare diseases, today reported financial results for the third quarter ended September 30, 2025. “Our ongoing efforts in operational execution and regulatory progress have yielded important developments in the third quarter and beginning...

– Revenue of $69 million from continuing operations and $14 million from discontinued operations –– Successfully closed $588 million convertible notes offering –– Announced plans to convert Washington site to support GB300s with advanced liquid cooling – TORONTO, Ontario and NEW YORK, Nov. 13, 2025 (GLOBE NEWSWIRE) — Bitfarms Ltd. (Nasdaq/TSX: BITF), a North American energy and digital infrastructure company, today reported its financial results for the third quarter ended September 30, 2025. All financial references are in U.S. dollars. “We continue to execute on our strategy to pivot from an international Bitcoin miner to a North American energy and digital infrastructure company,” stated CEO Ben Gagnon. “We recently announced our successful $588 million convertible note offering, alongside...

Third Quarter Revenue Increased 2.5% Period over Period with 42.3% EBITDA Growth Revenue for the First Nine Months Increased 5.6% Year Over Year Signs Existing Health System to 10 Year Extension and an Upgrade to their Gamma Knife System Conference Call Scheduled for 1:00 PM ET Today SAN FRANCISCO, Nov. 13, 2025 (GLOBE NEWSWIRE) — American Shared Hospital Services (NYSE American: AMS) (the “Company”), a leading provider of stereotactic radiosurgery equipment and advanced radiation therapy cancer treatment services through its equipment leasing and direct patient care services segments, today announced financial results for the third quarter ended September 30, 2025. Key Financial HighlightsQ3 2025 Revenue increased 2.5% period over period Q3 2025 Direct patient services revenue increased 9.4% period over period Q3...

Disciplined pullback aims to preserve high-quality member base, retention and engagement model, and platform efficiency. CHICAGO, Nov. 13, 2025 (GLOBE NEWSWIRE) — GoHealth, Inc. (NASDAQ: GOCO) (“GoHealth” or the “Company”), a leading health insurance marketplace and Medicare-focused digital health company, today announced financial results for the three and nine months ended September 30, 2025. The Company navigated a materially different Medicare Advantage environment by intentionally reducing Medicare Advantage volume, conserving liquidity, and preserving the core capabilities required to scale when market conditions stabilize. Based on our analysis, health plans continue to emphasize margin integrity, renewal stability, and long-term member value over raw enrollment growth. GoHealth anticipated this shift and aligned its operating...

Expects to Submit Conditional Marketing Approval Application in Europe for Iopofosine I 131 in Refractory (post-BTKi) Waldenstrom’s Macroglobulinemia in 2026 Following Advice and Guidance from Scientific Advice Working Party (SAWP) Initiated Phase 1b Study of CLR 125 for TNBC Received Rare Pediatric Drug Designation for Iopofosine I 131 in Inoperable Relapsed/Refractory Pediatric High-Grade Glioma (r/r pHGG) Company to Hold Webcast and Conference Call at 8:30 AM ET Today FLORHAM PARK, N.J., Nov. 13, 2025 (GLOBE NEWSWIRE) — Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery and development of drugs for the treatment of cancer, today announced financial results for the quarter ended September 30, 2025, and provided a corporate update. “Our productive engagement with...

NEW YORK, Nov. 13, 2025 (GLOBE NEWSWIRE) — Chicago Atlantic BDC, Inc. (“LIEN” or the “Company”) (NASDAQ: LIEN), a specialty finance company that has elected to be regulated as a business development company, today announced its financial results for the third quarter ended September 30, 2025. Third Quarter 2025 Highlights and Subsequent ActivityTotal gross investment income of $15.1 million. Interest income accounted for $13.8 million, of which $1.9 million was related to one-time pre-payment premiums from early payoffs Net investment income of $9.5 million, or $0.42 per weighted average share outstanding Total investment portfolio of $311.4 million at fair value Net asset value (“NAV”) per share was $13.27 on September 30, 2025 Board of Directors declared a dividend of $0.34 per share for the quarter ending December 31, 2025...

PERTH, Australia, Nov. 13, 2025 (GLOBE NEWSWIRE) — Alkane Resources Limited (“Alkane” or the “Company”) (ASX: ALK, OTC: ALKEF, TSX: ALK) is pleased to announce financial results for the first quarter ended 30 September 2025 (the “quarter” or “Q1 2026”). The Company’s condensed and consolidated interim financial result for the quarter, together with its Management’s Discussion and Analysis (“MD&A”) for the corresponding period, can be accessed under Alkane’s profile on www.sedar.com, on the Australian Securities Exchange (“ASX”) and on Alkane’s website at www.alkres.com. All currency references in this press release are in Australian dollars except as otherwise indicated. First Quarter 2026 Highlights:Strengthened Balance Sheet: Cash, bullion and listed investment balance of $191 million, after the repayment of the $45 million...

SHENZHEN, China, Nov. 13, 2025 (GLOBE NEWSWIRE) — Aurora Mobile Limited (“Aurora Mobile” or the “Company”) (NASDAQ: JG), a leading provider of customer engagement and marketing technology services in China, today announced its unaudited financial results for the third quarter ended September 30, 2025. Third Quarter 2025 Financial HighlightsRevenues were RMB90.9 million (US$12.8 million), an increase of 15% year-over-year. Cost of revenues was RMB27.1 million (US$3.8 million), an increase of 5% year-over-year. Gross profit was RMB63.8 million (US$9.0 million), an increase of 20% year-over-year. Total operating expenses were RMB64.4 million (US$9.0 million), an increase of 13% year-over-year. Net income was RMB0.7 million (US$92 thousand), compared with a net loss of RMB2.2 million for the same quarter last year. Net loss attributable...

Selskabsmeddelelse nr. 19 – 2025København, den 13. november 2025Kvartalsorientering for 3. kvartal 2025Selskabet offentliggør ikke finansiel information i kvartalsorienteringen.Det tidligere annoncerede køb af ejendommen beliggende Måløv Byvej 229, 2760 Måløv er gennemført den 14. august 2025.  Driften af ejendommen forløber som forventet. Selskabet har siden overtagelsen haft fokus på dialog med lejerne samt at sikre en effektiv overgang af ejendomsadministrationen.  Koncernens egenkapital pr. 30. september 2025 estimeres til DKK 9,2 mio., svarende til en indre værdi pr. aktie på DKK 3,7.  NTR Holding-koncernen forventer i 2025 uændret en omsætning i niveauet DKK 4 mio. og et resultat før kurs- og værdireguleringer i niveauet DKK 0 mio.  Bestyrelsen vil søge NTR Holding A/S afnoteret inden selskabets ordinære generalforsamling i 2026...

SHENZHEN, China, Nov. 13, 2025 (GLOBE NEWSWIRE) — Xunlei Limited (“Xunlei” or the “Company”) (Nasdaq: XNET), a leading technology company providing distributed cloud services in China, today announced its unaudited financial results for the third quarter ended September 30, 2025. Third Quarter 2025 Financial Highlights:Total revenues were US$126.4 million, representing an increase of 57.7% year-over-year.Subscription revenues were US$40.7 million, representing an increase of 22.3% year-over-year.Live-streaming and other services revenues were US$49.1 million, representing an increase of 127.1% year-over-year.Cloud computing revenues were US$36.6 million, representing an increase of 44.9% year-over-year.Gross profit was US$60.5 million, representing an increase of 49.6% year-over-year, and...